Molecular Biology of Head and Neck Cancer: Risks and Pathways
- 31 December 2008
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 22 (6), 1099-1124
- https://doi.org/10.1016/j.hoc.2008.08.007
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancerHead & Neck, 2008
- Integrating Radiotherapy With Epidermal Growth Factor Receptor Antagonists and Other Molecular Therapeutics for the Treatment of Head and Neck CancerInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Genetic polymorphisms in DNA base‐excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neckCancer, 2007
- Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neckBritish Journal of Cancer, 2007
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- The Hallmarks of CancerCell, 2000
- Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cellsEuropean Journal Of Cancer, 1993
- Cancer in Ataxia-telangiectasia patientsCancer Genetics and Cytogenetics, 1990